CoChat

Intra-Cellular Calcium Signaling Pathways (PKC, RAS/RAF/MAPK, PI3K) in Lamina Cribrosa Cells in Glaucoma

Open access
Irnaten, Mustapha, Duff, Aisling, Clark, Abbot, O’Brien, Colm · 2020 · Journal of Clinical Medicine

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Abstract

The lamina cribrosa (LC) is a key site of fibrotic damage in glaucomatous optic neuropathy and the precise mechanisms of LC change remain unclear. Elevated Ca2+ is a major driver of fibrosis, and therefore intracellular Ca2+ signaling pathways are relevant glaucoma-related mechanisms that need to be studied. Protein kinase C (PKC), mitogen-activated MAPK kinases (p38 and p42/44-MAPK), and the PI3K/mTOR axis are key Ca2+ signal transducers in fibrosis and we therefore investigated their expression and activity in normal and glaucoma cultured LC cells. We show, using Western immune-blotting, that hyposmotic-induced cellular swelling activates PKCα, p42/p44, and p38 MAPKs, the activity is transient and biphasic as it peaks between 2 min and 10 min. The expression and activity of PKCα, p38 and p42/p44-MAPKs are significantly (p < 0.05) increased in glaucoma LC cells at basal level, and at different time-points after hyposmotic stretch. We also found elevated mRNA expression of mRNA expression of PI3K, IP3R, mTOR, and CaMKII in glaucoma LC cells. This study has identified abnormalities in multiple calcium signaling pathways (PKCα, MAPK, PI3K) in glaucoma LC cells, which might have significant functional and therapeutic implications in optic nerve head (ONH) fibrosis and cupping in glaucoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm10010062

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Fibrosis related intracellular Ca2+ signaling pathways. (A). Schematic mechanism of key pro-fibrotic extracellular matrix (ECM) gene transcription regulation involving different signaling pathways. Including calcineurin/NFATc, PKCα, p38-MAPK, and p42/44-MAPK in lamina cribrosa (LC) cells. TGF-β, oxidative stress, and/or cell membrane stretch stimuli provoke [Ca2+]i movements from Ca2+ entry (through TRPC and L-type Ca2+ channels) and extrusion of Ca2+ from Endoplasmic Reticulum (ER), Ryanodine Receptor (RYR), and inositol triphosphate Receptor (IP3R). [Ca2+]i rise activates calmodulin, which in turn activates calcineurin. Activated calcineurin induces dephosphorylation of transcription factors of activated transcription factors of activated T-cells (NFATc), which next translocate to the nucleus to activate Ca2+ related genes including those involved in fibrosis in glaucoma. [Ca2+]i rise also induce a sequential phosphorylation of PKCα, and downstream series of phosphorylations of p38-MAPK, and p42/44-MAPK resulting in expression of Ca2+-dependent genes such as profibrotic ECM genes and ultimately proliferation of glaucoma LC cells. (B) Schematic illustration of the three modules (ERKs, JNKs, p38-MAPK). Stimuli, such as cell surface receptors including receptor tyrosin kinase (RTK), growth factor receptors, and G-protein coupled receptors (GPCR), activate up-stream protein kinases, which in turn activate downstream MAPKs. MAPKs signalling pathways are structured in modular cascades in which activation of upstream kinases lead to sequential activation of a MAPK module (MAPKKK, MAPKK, MAPK). MAPKKK phosphorylates (indicated by P) and activates MAPKK, which in turn phosphorylates and activates MAPK. Shown are the major MAPK pathway components, the JNK, and the p38-MAPK modules, and the various cellular responses including fibrosis elicited by MAPK control. MAPK: Mitogen-activated protein kinase; MAPKK: Mitogen-activated protein kinase kinas; MAPKKK: Mitogen-activated protein kinase kinase kinase.
Figure 1 Fibrosis related intracellular Ca2+ signaling pathways. (A). Schematic mechanism of key pro-fibrotic extracellular matrix (ECM) gene transcription regulation involving different signaling pathways. Including calcineurin/NFATc, PKCα, p38-MAPK, and p42/44-MAPK in lamina cribrosa (LC) cells. TGF-β, oxidative stress, and/or cell membrane stretch stimuli provoke [Ca2+]i movements from Ca2+ entry (through TRPC and L-type Ca2+ channels) and extrusion of Ca2+ from Endoplasmic Reticulum (ER), Ryanodine Receptor (RYR), and inositol triphosphate Receptor (IP3R). [Ca2+]i rise activates calmodulin, which in turn activates calcineurin. Activated calcineurin induces dephosphorylation of transcription factors of activated transcription factors of activated T-cells (NFATc), which next translocate to the nucleus to activate Ca2+ related genes including those involved in fibrosis in glaucoma. [Ca2+]i rise also induce a sequential phosphorylation of PKCα, and downstream series of phosphorylations of p38-MAPK, and p42/44-MAPK resulting in expression of Ca2+-dependent genes such as profibrotic ECM genes and ultimately proliferation of glaucoma LC cells. (B) Schematic illustration of the three modules (ERKs, JNKs, p38-MAPK). Stimuli, such as cell surface receptors including receptor tyrosin kinase (RTK), growth factor receptors, and G-protein coupled receptors (GPCR), activate up-stream protein kinases, which in turn activate downstream MAPKs. MAPKs signalling pathways are structured in modular cascades in which activation of upstream kinases lead to sequential activation of a MAPK module (MAPKKK, MAPKK, MAPK). MAPKKK phosphorylates (indicated by P) and activates MAPKK, which in turn phosphorylates and activates MAPK. Shown are the major MAPK pathway components, the JNK, and the p38-MAPK modules, and the various cellular responses including fibrosis elicited by MAPK control. MAPK: Mitogen-activated protein kinase; MAPKK: Mitogen-activated protein kinase kinas; MAPKKK: Mitogen-activated protein kinase kinase kinase.CC BY · PubMed Central
Figure 2 Western blot analysis of total and phospho-specific PKCα in normal and glaucoma LC cells. (A,B): typical Western immune-blotting analysis of PKCα in LC cell lysates in normal and glaucoma LC cells. Proteins (20 μg/lane) were separated on 10% electrophoresis gels, transferred to nitrocellulose membranes, and immunoblotted with phosphor-and total antibodies specific to PKCα (a 1:1000 dilution), respectively. Time-dependent expression of PKCα in LC cells exposed to isosmotic solution (resting conditions) and activity (phosphorylation) in response to hyposmotic-induced cell swelling. (C) Results are averages ± SE of at least 3 biological replicates obtained from three normal and three glaucoma LC cell patients. * p < 0.05 compared with time-matched controls (100%). The left panel represents the average data of PKCα expression under basal conditions (Ctrl) and at time-points of 1, 2, and 5 min of LC cells’ exposure to hyposmotic solution. The right panel shows the average data of PKCα expression/activity, under basal (Ctrl) and at time-points of 10, 20, and 30 min of LC cells’ treatment with hypotonic solution. The quantified data are presented in two separate bar graphs, to enhance the difference in PKCα expression/activity between normal and glaucoma LC cells. Note that the scale bar in the left panel (first 5 min) is twice that in the right panel (from 10 to 30 min). (D) Representative Western blot analysis of PKCα expression/activity in normal and glaucoma LC cells, illustrating a time-course experiment under isotonic (Ctrl) conditions and after 2, 10, and 60 min of exposure to hyposmotic solution. The time-points chosen here are the time-points where PKCα reached the two transient maximum peaks (2 min and 10 min), and the exposure to hypotonic cell stretch was extended to 60 min. (E) Average data ± SE of biological replicates. * p < 0.05 compared with time-matched controls (100%). To confirm equal amounts of protein loading, membranes were washed and reblotted with beta-actin antibody (Figure 2A,B).
Figure 2 Western blot analysis of total and phospho-specific PKCα in normal and glaucoma LC cells. (A,B): typical Western immune-blotting analysis of PKCα in LC cell lysates in normal and glaucoma LC cells. Proteins (20 μg/lane) were separated on 10% electrophoresis gels, transferred to nitrocellulose membranes, and immunoblotted with phosphor-and total antibodies specific to PKCα (a 1:1000 dilution), respectively. Time-dependent expression of PKCα in LC cells exposed to isosmotic solution (resting conditions) and activity (phosphorylation) in response to hyposmotic-induced cell swelling. (C) Results are averages ± SE of at least 3 biological replicates obtained from three normal and three glaucoma LC cell patients. * p < 0.05 compared with time-matched controls (100%). The left panel represents the average data of PKCα expression under basal conditions (Ctrl) and at time-points of 1, 2, and 5 min of LC cells’ exposure to hyposmotic solution. The right panel shows the average data of PKCα expression/activity, under basal (Ctrl) and at time-points of 10, 20, and 30 min of LC cells’ treatment with hypotonic solution. The quantified data are presented in two separate bar graphs, to enhance the difference in PKCα expression/activity between normal and glaucoma LC cells. Note that the scale bar in the left panel (first 5 min) is twice that in the right panel (from 10 to 30 min). (D) Representative Western blot analysis of PKCα expression/activity in normal and glaucoma LC cells, illustrating a time-course experiment under isotonic (Ctrl) conditions and after 2, 10, and 60 min of exposure to hyposmotic solution. The time-points chosen here are the time-points where PKCα reached the two transient maximum peaks (2 min and 10 min), and the exposure to hypotonic cell stretch was extended to 60 min. (E) Average data ± SE of biological replicates. * p < 0.05 compared with time-matched controls (100%). To confirm equal amounts of protein loading, membranes were washed and reblotted with beta-actin antibody (Figure 2A,B).CC BY · PubMed Central
Figure 3 Western blot analysis of total and phospho-p38-MAPK in normal and glaucoma LC cells. Equal amounts of cellular proteins (20 μg/lane), were separated on a 10% electrophoresis gel, transferred to a nitrocellulose membrane, and immunoblotted with a 1:1000 dilution of phospho and total antibodies specifically directed against p38-MAPK, respectively. (A), (Top left panel), representative p38-MAPK Western blot of LC cells exposed to isotonic physiological solution (for at least 15 min to obtain a stable baseline) and (B), (Top right panel), LC cells treated with hyposmotic solution at time-points of 2, 5, 10, 20, and 30 min. (C) Averages ± SE of at least three biological replicates comparing the expression and activity of p38-MAPK in normal and glaucoma LC cells. * p < 0.05 was compared with time-matched controls (100%). Average data of expression and activity (phosphprylation) levels of p38-MAPK were normalized to total p38-MAPK levels. There was a significant increase in phosphorylated p38-MAPK (p−p38-MAPK) protein expression at basal conditions (Ctrl) and p38-MAPK activity (phosphorylation) at time-points of 2, 5, and 10 min, but no significant increase in p38-MAPK activity was found at 20 and 30 min after exposure to hyposmotic solution.
Figure 3 Western blot analysis of total and phospho-p38-MAPK in normal and glaucoma LC cells. Equal amounts of cellular proteins (20 μg/lane), were separated on a 10% electrophoresis gel, transferred to a nitrocellulose membrane, and immunoblotted with a 1:1000 dilution of phospho and total antibodies specifically directed against p38-MAPK, respectively. (A), (Top left panel), representative p38-MAPK Western blot of LC cells exposed to isotonic physiological solution (for at least 15 min to obtain a stable baseline) and (B), (Top right panel), LC cells treated with hyposmotic solution at time-points of 2, 5, 10, 20, and 30 min. (C) Averages ± SE of at least three biological replicates comparing the expression and activity of p38-MAPK in normal and glaucoma LC cells. * p < 0.05 was compared with time-matched controls (100%). Average data of expression and activity (phosphprylation) levels of p38-MAPK were normalized to total p38-MAPK levels. There was a significant increase in phosphorylated p38-MAPK (p−p38-MAPK) protein expression at basal conditions (Ctrl) and p38-MAPK activity (phosphorylation) at time-points of 2, 5, and 10 min, but no significant increase in p38-MAPK activity was found at 20 and 30 min after exposure to hyposmotic solution.CC BY · PubMed Central
Figure 4 Western blot analysis of total and phospho-p42/44-MAPK in normal and glaucoma LC cells. Equal amount of 20 μg/lane of cell protein was loaded, separated on a 10% electrophoresis gel, transferred to a nitrocellulose membrane, and immunoblotted with phospho p42/p44-MAPK (p−p42/44 MAPK) and total (p−p42/44 MAPK) primary antibodies, respectively. (A) Top left panel: representative Western blot of LC cells subjected to isotonic physiological solution (for 15 min) and (B) Top right panel: representative Western blot of LC cells subjected to hyposmotic-induced cell swelling solution at time-point of 1, 2, 5, 10, 20, and 30 min. (C) Averages ± SE of three biological replicates of normal controls and glaucoma LC cells. The average data of expression/activity levels of p42/44-MAPK were expressed as a ratio of the total p42/44-MAPK levels. Values which are significantly different to controls are denoted by asterisks. * p < 0.05 was compared with time-matched controls (100%). Note a significant elevation of phosphorylated hyposmotic-induced cell swelling (p−p42/44-MAPK) protein expression at basal conditions (Ctrl) and p42/44-MAPK activity (phosphorylation) at time-points of 1, 2, 5, and 10 min, 20, and 30 min after exposure to hyposmotic-induced cell swelling solution.
Figure 4 Western blot analysis of total and phospho-p42/44-MAPK in normal and glaucoma LC cells. Equal amount of 20 μg/lane of cell protein was loaded, separated on a 10% electrophoresis gel, transferred to a nitrocellulose membrane, and immunoblotted with phospho p42/p44-MAPK (p−p42/44 MAPK) and total (p−p42/44 MAPK) primary antibodies, respectively. (A) Top left panel: representative Western blot of LC cells subjected to isotonic physiological solution (for 15 min) and (B) Top right panel: representative Western blot of LC cells subjected to hyposmotic-induced cell swelling solution at time-point of 1, 2, 5, 10, 20, and 30 min. (C) Averages ± SE of three biological replicates of normal controls and glaucoma LC cells. The average data of expression/activity levels of p42/44-MAPK were expressed as a ratio of the total p42/44-MAPK levels. Values which are significantly different to controls are denoted by asterisks. * p < 0.05 was compared with time-matched controls (100%). Note a significant elevation of phosphorylated hyposmotic-induced cell swelling (p−p42/44-MAPK) protein expression at basal conditions (Ctrl) and p42/44-MAPK activity (phosphorylation) at time-points of 1, 2, 5, and 10 min, 20, and 30 min after exposure to hyposmotic-induced cell swelling solution.CC BY · PubMed Central
Figure 5 Transcription of IP3R, CaMKII, PI3K, and mTOR in normal and glaucoma LC cells. Average data of qRT-PCR comparing the transcription levels of IP3R, CaMKII, PI3K and mTOR in three 3 normal and 3 glaucoma LC cells. Note that transcription levels of IP3R, CaMKII, PI3K, and mTOR are all significantly up-regulated in glaucoma LC cells. Values which are significantly different to controls are denoted by asterisks (* p < 0.05 vs. Control). 18S is the housekeeping control gene. The experiments were performed and reproduced on 3 separate experiments on LC cells from 3 normal controls and from 3 glaucoma donors.
Figure 5 Transcription of IP3R, CaMKII, PI3K, and mTOR in normal and glaucoma LC cells. Average data of qRT-PCR comparing the transcription levels of IP3R, CaMKII, PI3K and mTOR in three 3 normal and 3 glaucoma LC cells. Note that transcription levels of IP3R, CaMKII, PI3K, and mTOR are all significantly up-regulated in glaucoma LC cells. Values which are significantly different to controls are denoted by asterisks (* p < 0.05 vs. Control). 18S is the housekeeping control gene. The experiments were performed and reproduced on 3 separate experiments on LC cells from 3 normal controls and from 3 glaucoma donors.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 30

Metadata

Authors
Irnaten, M., Duff, A., Clark, A., & O’Brien, C.
Affiliations
  • Mater Misericordiae University Hospital (IE)
  • Milton Medical Centre New South Wales, Milton, NSW 2538, Australia
  • University of North Texas Health Science Center (US)
  • Department Ophthalmology, Mater Misericordiae University Hospital, D07 R2WY Dublin, Ireland
Corresponding author
Irnaten, Mustapha
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2020-12-26
Volume
10
Issue
1
Pages
62
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3115892654
Cited by
27
References
55
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 10 · 2022: 1 · 2021: 2
FWCI
2.58
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
International Glaucoma Association
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
Keywords
lamina cribrosa, glaucoma, intracellular calcium signaling, protein kinase C alpha, mitogen-activated protein kinase, cell swelling, IP3 receptor, CaMKII, glaucomatous optic neuropathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intra-Cellular Calcium Signaling Pathways (PKC, RAS/RAF/MAPK, PI3K) in Lamina Cribrosa Cells in Glaucoma. https://app.cochat.ai/papers/10.3390/jcm10010062
The paper
Irnaten, M., Duff, A., Clark, A., & O’Brien, C. (2020). Intra-Cellular Calcium Signaling Pathways (PKC, RAS/RAF/MAPK, PI3K) in Lamina Cribrosa Cells in Glaucoma. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10010062

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.